Pharming Group N.V. (PHAR)

Pharming Group had revenue of $79.09M in the quarter ending March 31, 2025, with 42.29% growth. This brings the company's revenue in the last twelve months to $320.71M, up 24.13% year-over-year. In the year 2024, Pharming Group had annual revenue of $297.20M with 21.15% growth.

• Revenue (ttm): $320.71M
• Revenue Growth: +24.13%
• P/S Ratio: 2.31
• Revenue / Employee: $793,832
• Employees: 404
• Market Cap: 742.30M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	297.20M	51.88M	21.15%
Dec 31, 2023	245.32M	39.69M	19.30%
Dec 31, 2022	205.62M	6.75M	3.39%
Dec 31, 2021	198.87M	-13.30M	-6.27%
Dec 31, 2020	212.17M	22.79M	12.03%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.